A recent comprehensive analysis of nearly 15,000 Medicare users has significantly reshaped the understanding of virtual care, revealing its indispensable role in managing a vast array of physical health conditions. Contrary to the widespread belief that telehealth primarily serves mental and
The burgeoning market for GLP-1 weight-loss medications created a gold rush for telehealth companies, but for Hims & Hers, a bold move into this lucrative space has rapidly devolved into a multi-front battle with regulators and pharmaceutical giants. The company's recent announcement that it would
Today we're joined by Ivan Kairatov, a biopharma expert with a deep understanding of the technological innovations driving the industry, particularly in oncology. His work at the intersection of research and development gives him a unique perspective on the recent FDA clearance for PharmaResearch’s
Medical diagnostics often present a difficult choice between speed, detail, and safety, forcing clinicians to navigate a complex landscape of imaging technologies, each with its own set of compromises. While some methods offer rapid, real-time views, they may lack the resolution needed for a
The staggering reality of cancer in Europe continues to cast a long shadow, with over 3.2 million new diagnoses and 1.5 million lives lost each year, underscoring the urgent need for a unified and effective response. Amid this challenge, a powerful new paradigm in oncology has emerged, encapsulated
A brief but deeply impactful federal government shutdown has thrown crucial healthcare services into disarray, abruptly halting the pandemic-era Medicare telehealth and Hospital-at-Home flexibilities that have become a lifeline for millions of Americans. This funding lapse, triggered by a
